Articles Tagged With:
-
Outcome of PCSK9 Inhibitor-treated Patients
In a recent study, proprotein convertase subtilisin-kexin type 9 serine protease inhibitors significantly improve lipid profiles and reduce all-cause mortality, but were associated with more neurocognitive adverse events than placebo.
-
Teens Aren’t Completing HPV Vaccine Series — Research Tells Us Why
Only 40% of females and 22% of males complete the series of three HPV vaccine doses. Now we know why. -
Global Village: After Ebola and Zika, Patient Admitted to U.S. Hospital with Lassa Fever
As this issue went to press, the CDC confirmed that a patient admitted to Emory University Hospital’s Serious Communicable Diseases Unit has Lassa fever, a hemorrhagic virus endemic in parts of West Africa.
-
Zika Update: U.S. Approaching 200 Cases
As confirmed cases of the Zika virus disease continue to mount in the United States, frontline providers are scrambling to ensure that appropriate patients are screened for the illness, and to minimize the risk of transmission, especially to pregnant women.
-
Mind Over Matter: Testing a Non-opioid Pain Relief Alternative
New study provides evidence of a brain process that reduces pain through mindful meditation.
-
Increasing Job Requirements Warrant More Funding for IPs, Epidemiologists
As infection prevention and healthcare epidemiology continue to undergo a dramatic transformation in duties and responsibilities, resources and program support are lagging in many hospitals even as a Zika virus outbreak follows closely on the heels of Ebola.
-
The One and the Many: Experts Urge New Paradigm on Antibiotic Resistance
While the widespread overuse and misuse of antibiotics is frequently cited in discussions of increasing bacterial resistance, there are instances where even correct use for an individual patient raises the question of potential harm to others. A prevailing paradox in antibiotic therapy is that what is good for the one may be bad for the many.
-
CDC Atlas Tool Maps out Resistant Bug Threat
Trying to get a literal picture of the prevalence and geographic distribution of antibiotic-resistant bacteria in the U.S., the CDC has created an electronic, interactive map that can be accessed on the Web or through a mobile app. The Antibiotic Resistance Patient Safety Atlas reports the percentage of various healthcare-associated infections caused by antibiotic-resistant bacteria.
-
Prevent the Bug, Save the Drug:
Once largely consigned to separate silos, infection prevention and antibiotic stewardship are starting to show signs of a powerful partnership. The CDC’s most recent update on the threat of antibiotic-resistant bacteria emphasizes that drug stewardship and infection control must essentially be inseparable if they are going to be successful.
-
Analysis: More Money to Docs Leads to More Brand-name Drug Prescriptions
An investigation demonstrates a link between how doctors prescribe medication and money they receive from pharmaceutical companies.